AGORA INC-ADR (API)

US00851L1035 - ADR

4.43  +0.06 (+1.37%)

After market: 4.43 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to API. API was compared to 280 industry peers in the Software industry. The financial health of API is average, but there are quite some concerns on its profitability. While showing a medium growth rate, API is valued expensive at the moment.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year API has reported negative net income.
In the past year API has reported a negative cash flow from operations.
API had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: API reported negative operating cash flow in multiple years.

1.2 Ratios

API has a Return On Assets (-6.58%) which is in line with its industry peers.
API's Return On Equity of -7.89% is in line compared to the rest of the industry. API outperforms 51.28% of its industry peers.
Industry RankSector Rank
ROA -6.58%
ROE -7.89%
ROIC N/A
ROA(3y)-11.88%
ROA(5y)-23.19%
ROE(3y)-13.1%
ROE(5y)-25.93%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

API's Gross Margin of 63.16% is in line compared to the rest of the industry. API outperforms 41.76% of its industry peers.
In the last couple of years the Gross Margin of API has declined.
The Profit Margin and Operating Margin are not available for API so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y-2.28%

More info and screens

4

2. Health

2.1 Basic Checks

API does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for API has been reduced compared to 1 year ago.
API has more shares outstanding than it did 5 years ago.
The debt/assets ratio for API is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 1.55, we must say that API is in the distress zone and has some risk of bankruptcy.
API's Altman-Z score of 1.55 is on the low side compared to the rest of the industry. API is outperformed by 61.54% of its industry peers.
API has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of API (0.06) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 1.55
ROIC/WACCN/A
WACC9.74%

2.3 Liquidity

API has a Current Ratio of 6.15. This indicates that API is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 6.15, API belongs to the top of the industry, outperforming 91.21% of the companies in the same industry.
A Quick Ratio of 6.15 indicates that API has no problem at all paying its short term obligations.
API has a Quick ratio of 6.15. This is amongst the best in the industry. API outperforms 91.21% of its industry peers.
Industry RankSector Rank
Current Ratio 6.15
Quick Ratio 6.15

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 35.62% over the past year.
Looking at the last year, API shows a decrease in Revenue. The Revenue has decreased by -7.40% in the last year.
API shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.50% yearly.
EPS 1Y (TTM)35.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.04%
Revenue 1Y (TTM)-7.4%
Revenue growth 3Y1.94%
Revenue growth 5Y26.5%
Sales Q2Q%-9.84%

3.2 Future

The Earnings Per Share is expected to grow by 27.49% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 6.91% on average over the next years.
EPS Next Y47.69%
EPS Next 2Y38.15%
EPS Next 3Y27.49%
EPS Next 5YN/A
Revenue Next Year-6.1%
Revenue Next 2Y-0.47%
Revenue Next 3Y3.83%
Revenue Next 5Y6.91%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

API reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for API. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as API's earnings are expected to grow with 27.49% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.15%
EPS Next 3Y27.49%

More info and screens

0

5. Dividend

5.1 Amount

API does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AGORA INC-ADR

NASDAQ:API (1/3/2025, 8:20:08 PM)

After market: 4.43 0 (0%)

4.43

+0.06 (+1.37%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-25 2024-11-25/amc
Earnings (Next)N/A N/A
Inst Owners33.4%
Inst Owner Change-2.19%
Ins Owners2.23%
Ins Owner Change0%
Market Cap404.38M
Analysts46.67
Price Target4.13 (-6.77%)
Short Float %3.56%
Short Ratio1.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-292.5%
Min EPS beat(2)-543.56%
Max EPS beat(2)-41.44%
EPS beat(4)1
Avg EPS beat(4)-126.5%
Min EPS beat(4)-543.56%
Max EPS beat(4)89%
EPS beat(8)1
Avg EPS beat(8)-86.71%
EPS beat(12)1
Avg EPS beat(12)-64.13%
EPS beat(16)4
Avg EPS beat(16)-38.26%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)32.79%
PT rev (3m)43.87%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-9.58%
EPS NY rev (3m)-12.65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-5.07%
Revenue NY rev (3m)-5.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3
P/FCF N/A
P/OCF N/A
P/B 0.7
P/tB 0.7
EV/EBITDA N/A
EPS(TTM)-0.47
EYN/A
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)-0.5
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS1.48
BVpS6.32
TBVpS6.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.58%
ROE -7.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 63.16%
FCFM N/A
ROA(3y)-11.88%
ROA(5y)-23.19%
ROE(3y)-13.1%
ROE(5y)-25.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y-2.28%
F-Score5
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 615.69%
Cap/Sales 22.93%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.15
Quick Ratio 6.15
Altman-Z 1.55
F-Score5
WACC9.74%
ROIC/WACCN/A
Cap/Depr(3y)678.62%
Cap/Depr(5y)516.26%
Cap/Sales(3y)48.77%
Cap/Sales(5y)32.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.04%
EPS Next Y47.69%
EPS Next 2Y38.15%
EPS Next 3Y27.49%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.4%
Revenue growth 3Y1.94%
Revenue growth 5Y26.5%
Sales Q2Q%-9.84%
Revenue Next Year-6.1%
Revenue Next 2Y-0.47%
Revenue Next 3Y3.83%
Revenue Next 5Y6.91%
EBIT growth 1Y12.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year57.28%
EBIT Next 3Y19.33%
EBIT Next 5YN/A
FCF growth 1Y81.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y65.51%
OCF growth 3YN/A
OCF growth 5YN/A